The global electronic clinical outcome assessment solutions market witnessed a size of USD 1.36 Billion in 2022 and is projected to reach USD 4.78 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15% throughout the forecast period. The primary driver of revenue growth in the market is the increasing focus on patient-centric drug development. By leveraging electronic Clinical Outcome Assessment (eCOA) solutions, patients can conveniently complete surveys and questionnaires remotely using their own devices, resulting in a more patient-friendly approach to data collection. This approach has the potential to enhance patient engagement, as well as improve data quality and accuracy. Moreover, eCOA systems alleviate the burden on clinical sites by eliminating the need for manual data entry and paper-based data collection. https://www.reportsanddata.com/report-detail/electronic-clinical-outcome-assessment-ecoa-solutions-market